English
Français
Deutsch
Italiano
Português
Русский
Español
ไทย
Türkçe
简体中文
日本語
한국어
हिन्दी
Topline
Abortion drug mifepristone will remain available nationwide, at least for now, as an appeals court paused partially put on hold a controversial lower court ruling that blocked the medication’s federal approval, ensuring restricted access to the drug at least while the appeals process plays out.
Key Facts
The 5th Circuit Court of Appeals’ ruling put on hold U.S. District Judge Matthew Kacsmaryk’s controversial decision to suspend FDA approval of the drug.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
